PREVENTION OF VASCULOPATHY AND NEPHROPATHY IN METABOLIC SYNDROME
PREVENTION OF VASCULOPATHY AND NEPHROPATHY IN METABOLIC SYNDROME
批准号:
7173341
负责人:
MICHAEL S GOLIGORSKY
金额:
$29.35万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-01-01 至 2011-01-31
关键词:
3-nitrotyrosineAdvanced Glycosylation End ProductsAging-Related ProcessAnimalsAntioxidantsApoptosisApoptoticAtherosclerosisBiochemicalCDKN2A geneCardiovascular systemCell AgingCell CountCell CycleCell SizeCellsCessation of lifeCollagenDecelerationDevelopmentDiabetes MellitusDisruptionEndothelial CellsEnrollmentEpidemicEventExtracellular Matrix ProteinsExtravasationFatty acid glycerol estersFructoseFunctional disorderGalactosidaseGangliosidesGeneral PopulationHumanImage AnalysisIn VitroIncidenceInsulin ResistanceInvestigationKidneyKidney DiseasesLeadLifeLightMediatingMetabolicMetabolic syndromeMicrocirculationMitochondriaMitochondrial ProteinsModelingMolecularMolecular TargetMorphologyMusNorth AmericaObesityOxidative StressOxygen ConsumptionPathway interactionsPatientsPermeabilityPeroxonitritePersonal SatisfactionPhase II Clinical TrialsPhenotypePopulationPremature aging syndromePreventionProductionProtein Kinase CProteinsRattusRoleSuperoxidesSyndromeTP53 geneTechniquesTreatment EfficacyTumor Necrosis Factor-alphaUmbilical veinVideo Microscopyactivation productantioxidant therapybaseconceptdaydesigndiabeticdiabetic ratebselenfeedinghuman TNF proteinin vivointravital fluorescence microscopymitochondrial dysfunctionnon-diabeticoxidized low density lipoproteinpreventreceptor for advanced glycation endproductsresearch studysenescence
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Accelerated atherosclerosis and premature aging of the cardiovascular system in patients with diabetes mellitus and metabolic syndrome have acquired epidemic proportions. Our previous studies of endothelial cells subjected to a microenvironment emulating the diabetic milieu revealed accelerated development of cell senescence. Based on the observations that the expression of nitrotyrosine-modified proteins was enhanced in the prematurely senescent cells and peroxynitrite treatment of intact cells led to premature senescence, we treated endothelial cells with a bona fide peroxynitrite scavenger/antioxidant ebselen. Such a treatment was associated with the prevention and reversal of premature senescence. These findings prompted us to investigate the molecular mechanism(s) of premature cell senescence, effects of ebselen on premature endothelial cell senescence in a model of metabolic syndrome - Zucker diabetic rats, and examine the development of vasculopathy in these animals. We hypothesize that oxidative stress/peroxynitrite-induced lysosomal dysfunction initiates endothelial cell senescence and accumulation of gangliosides, a molecular switch from senescence to apoptosis - events underpinning the progression of vasculopathy. In vitro and in vivo studies employing image analysis and fluorescence intravital microscopy, biochemical techniques to detect leakage of lysosomal and mitochondrial proteins as well as accumulation of gangliosides, and quantitative analysis of the markers of cell cycle are designed to investigate molecular and cellular mechanisms of premature senescence and apoptosis. In vivo studies of the Zucker diabetic fat rat treated with ebselen will be conducted to examine the possibility of preventing and reversing macro- and micro-vasculopathy (nephropathy) in this syndrome. The investigations may shed light on mechanisms of premature senescence of endothelial cells, role of peroxynitrite in initiating it, and potential therapeutic efficacy of peroxynitrite scavenging in amelioration of vasculopathy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Glycocalyx repair in sepsis using liposomal carriers of preassembled glycocalyx
-
批准号:10428550
-
项目类别:
-
资助金额:$54.12万
-
财政年份:2019
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
Glycocalyx repair in sepsis using liposomal carriers of preassembled glycocalyx
-
批准号:10218261
-
项目类别:
-
资助金额:$54.12万
-
财政年份:2019
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
ENDOTHELIAL DYSFUNCTION, NITRIC OXIDE AND RENAL FAILURE
-
批准号:7990202
-
项目类别:
-
资助金额:$9.67万
-
财政年份:2009
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
Weibel - Palade Bodies - Sentinels of Acute Ischemia
-
批准号:7921552
-
项目类别:
-
资助金额:$37.78万
-
财政年份:2009
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
PREVENTION OF VASCULOPATHY AND NEPHROPATHY IN METABOLIC SYNDROME
-
批准号:7990210
-
项目类别:
-
资助金额:$10.1万
-
财政年份:2009
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
Weibel - Palade Bodies - Sentinels of Acute Ischemia
-
批准号:8298636
-
项目类别:
-
资助金额:$33.89万
-
财政年份:2009
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
Weibel - Palade Bodies - Sentinels of Acute Ischemia
-
批准号:8496014
-
项目类别:
-
资助金额:$32.71万
-
财政年份:2009
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
Weibel - Palade Bodies - Sentinels of Acute Ischemia
-
批准号:7700338
-
项目类别:
-
资助金额:$38.16万
-
财政年份:2009
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
Weibel - Palade Bodies - Sentinels of Acute Ischemia
-
批准号:8079698
-
项目类别:
-
资助金额:$33.89万
-
财政年份:2009
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
VASCULAR PERMEABILITY IN DIABETIC NEPHROPATHY
-
批准号:6342524
-
项目类别:
-
资助金额:$21.35万
-
财政年份:1999
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
PREVENTION OF VASCULOPATHY AND NEPHROPATHY IN METABOLIC SYNDROME
-
批准号:7341755
-
项目类别:
-
资助金额:$28.76万
-
财政年份:1999
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
PREVENTION OF VASCULOPATHY AND NEPHROPATHY IN METABOLIC SYNDROME
-
批准号:7765494
-
项目类别:
-
资助金额:$28.47万
-
财政年份:1999
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
Prevent Vasculopathy and Nephropathy in Metabolic Syndro
-
批准号:7040269
-
项目类别:
-
资助金额:$31.37万
-
财政年份:1999
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
VASCULAR PERMEABILITY IN DIABETIC NEPHROPATHY
-
批准号:2716760
-
项目类别:
-
资助金额:$22.61万
-
财政年份:1999
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
VASCULAR PERMEABILITY IN DIABETIC NEPHROPATHY
-
批准号:6626968
-
项目类别:
-
资助金额:$21.92万
-
财政年份:1999
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
VASCULAR PERMEABILITY IN DIABETIC NEPHROPATHY
-
批准号:6688324
-
项目类别:
-
资助金额:$29.78万
-
财政年份:1999
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
PREVENTION OF VASCULOPATHY AND NEPHROPATHY IN METABOLIC SYNDROME
-
批准号:7568804
-
项目类别:
-
资助金额:$28.76万
-
财政年份:1999
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
VASCULAR PERMEABILITY IN DIABETIC NEPHROPATHY
-
批准号:6489713
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1999
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
VASCULAR PERMEABILITY IN DIABETIC NEPHROPATHY
-
批准号:6138083
-
项目类别:
-
资助金额:$20.79万
-
财政年份:1999
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
NITRIC OXIDE IN DEFENSE OF PERITONEAL CAVITY AGAINST MICROBIAL PATHOGENS--CAPD
-
批准号:6283027
-
项目类别:
-
资助金额:$2.44万
-
财政年份:1998
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
海外基金